Prestige Consumer Healthcare (PBH) Capital Expenditures (2010 - 2025)

Prestige Consumer Healthcare's Capital Expenditures history runs 16 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• On a quarterly basis, Capital Expenditures rose 93.36% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $9.4 million, a 19.76% increase from a year earlier, with the FY2025 full-year figure at $8.2 million, down 13.88% from the prior year.
• Capital Expenditures climbed to $3.0 million in Q4 2025 per PBH's latest filing, from $2.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $4.9 million in Q1 2021 and bottomed at $838000.0 in Q2 2025.
• The 5-year median for Capital Expenditures is $2.2 million (2021), against an average of $2.3 million.
• Across the five-year window, Capital Expenditures sank 69.64% in 2021 and soared 93.36% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $2.2 million in 2021, then decreased by 19.11% to $1.8 million in 2022, then grew by 10.7% to $2.0 million in 2023, then fell by 21.54% to $1.6 million in 2024, then surged by 93.36% to $3.0 million in 2025.
• Per Business Quant, the three latest PBH Capital Expenditures figures stand at $3.0 million (Q4 2025), $2.1 million (Q3 2025), and $838000.0 (Q2 2025).